Long-term outcomes of gemcitabine and cisplatin in patients with recurrent or metastatic esophageal squamous cell carcinoma: a phase II trial
文献类型：期刊论文
| 刊名 | CHINESE MEDICAL JOURNAL
 |
| 出版日期 | 2011 |
| 卷号 | 124 |
| 关键词 | PLUS CISPLATIN ONCOLOGY-GROUP CANCER CHEMOTHERAPY DOCETAXEL chemotherapy gemcitabine cisplatin esophageal cancer |
| ISSN号 | 0366-6999 |
| 其他题名 | Long-term outcomes of gemcitabine and cisplatin in patients with recurrent or metastatic esophageal squamous cell carcinoma: a phase II trial |
| 英文摘要 | Background Esophageal cancer is the sixth most common cause of cancer-related death worldwide. Prior studies had demonstrated potential synergistic antitumor activity of gemcitabine in combination with cisplatin. Therefore, we studied the efficacy and tolerability of such combination for esophageal cancer. |
| 资助项目 | [Beijing municipal science & technology commission] |
| 语种 | 英语 |
| CSCD记录号 | CSCD:4389215 |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/58791]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 推荐引用方式 GB/T 7714 | . Long-term outcomes of gemcitabine and cisplatin in patients with recurrent or metastatic esophageal squamous cell carcinoma: a phase II trial[J]. CHINESE MEDICAL JOURNAL,2011,124. |
| APA | (2011).Long-term outcomes of gemcitabine and cisplatin in patients with recurrent or metastatic esophageal squamous cell carcinoma: a phase II trial.CHINESE MEDICAL JOURNAL,124. |
| MLA | "Long-term outcomes of gemcitabine and cisplatin in patients with recurrent or metastatic esophageal squamous cell carcinoma: a phase II trial".CHINESE MEDICAL JOURNAL 124(2011). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。